The Latest Trading Price of Kisaan Parivar Industries Ltd is ₹ 9.91 as of 30 Oct 15:30
. The P/E Ratio of Kisaan Parivar Industries Ltd changed from 11.1 on March 2024 to 17.1 on March 2025 . This represents a CAGR of 24.12% over 2 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 47.8 on March 2025 . This represents a CAGR of 4.92% over 5 years The Market Cap of Kisaan Parivar Industries Ltd changed from ₹ 1.92 crore on March 2021 to ₹ 30.87 crore on March 2025 . This represents a CAGR of 74.28% over 5 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 102.13 crore on March 2025 . This represents a CAGR of 109.35% over 5 years The revenue of Kisaan Parivar Industries Ltd for the Mar '26 is ₹ 0.5 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Kisaan Parivar Industries Ltd for the Mar '26 is ₹ -0.31 crore as compare to the Dec '25 ebitda of ₹ -0.06 crore. This represent the growth of 416.67% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Kisaan Parivar Industries Ltd changed from ₹ 0.53 crore to ₹ -0.18 crore over 8 quarters. This represents a CAGR of NaN%
The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98%
The Dividend Payout of Kisaan Parivar Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Kisaan Parivar Industries Ltd
Kisaan Parivar Industries Limited was initially incorporated as Richirich Leasing and Finance Limited on March 7, 1986.
The name of the Company was changed to Richirich Agro Limited dated March 26, 1992 and again to Richirich Inventures Limited during 2007-08.
Subsequently, name of the Company has been changed from Richirich Inventures Limited to Kisaan Parivar Industries Limited vide fresh Certificate of Incorporation dated 5th April, 2024.
Initially, the Company was engaged in providing various services such as selection of property, negotiation, finance, documentation, and legal support services and further offer the services for residential, commercial, and retail properties, as well as for non agricultural land.
The Company originally operated its 200 M.T. per day Solvent extraction in Rajasthan at Jodhpur.
About Welcure Drugs & Pharmaceuticals Ltd
Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc.
WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes.
Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.
FAQs for the comparison of Kisaan Parivar Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd
Which company has a larger market capitalization, Kisaan Parivar Industries Ltd or Welcure Drugs & Pharmaceuticals Ltd?
Market cap of Kisaan Parivar Industries Ltd is 8 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr
What are the key factors driving the stock performance of Kisaan Parivar Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd?
The stock performance of Kisaan Parivar Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Kisaan Parivar Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd?
As of October 31, 2026, the Kisaan Parivar Industries Ltd stock price is INR ₹9.91. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.
How do dividend payouts of Kisaan Parivar Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?
To compare the dividend payouts of Kisaan Parivar Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.